Targeting the tumor vascular compartment to improve conventional cancer therapy
- 31 October 2004
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (10) , 536-542
- https://doi.org/10.1016/j.tips.2004.08.008
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitorsJournal of Clinical Investigation, 2003
- Tumor Vessel Development and Maturation Impose Limits on the Effectiveness of Anti-Vascular TherapyThe American Journal of Pathology, 2003
- Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene deliveryThe FASEB Journal, 2002
- Pharmacological modifications of the partial pressure of oxygen in murine tumors: Evaluation using in vivo EPR oximetryMagnetic Resonance in Medicine, 1999
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- A cancer therapy resistant to resistanceNature, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971